Summary

Persistence Market Research has recently released a comprehensive report on the worldwide market for pain management therapeutics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global pain management therapeutics market from 2025 to 2032.

Key Insights:

•Pain Management Therapeutics Market Size (2025E): USD 79.7 Billion
•Projected Market Value (2032F): USD 103.0 Billion
•Global Market Growth Rate (CAGR 2025 to 2032): 3.7%

Pain Management Therapeutics Market - Report Scope:

Pain management therapeutics encompass a broad spectrum of pharmaceutical drugs and treatment modalities designed to alleviate chronic and acute pain resulting from various medical conditions, including arthritis, cancer, post-surgical pain, neuropathy, and lower back disorders. This market caters to a wide array of healthcare settings, including hospitals, pain clinics, ambulatory surgical centers, and homecare environments. Therapeutic classes include opioids, NSAIDs, anticonvulsants, antidepressants, anesthetics, and emerging biologics. Market expansion is driven by the growing prevalence of chronic pain disorders, the aging population, and increasing patient demand for effective pain relief solutions with improved safety profiles.

Market Growth Drivers:

The global pain management therapeutics market is propelled by several key factors, including the rising incidence of chronic conditions such as osteoarthritis, diabetic neuropathy, and cancer-related pain. The growing elderly population, which is more susceptible to pain-related ailments, significantly boosts demand for both pharmacological and non-pharmacological pain management approaches. Technological advancements, including the development of targeted drug delivery systems and non-opioid analgesics, offer enhanced efficacy and reduced side effects, contributing to increased adoption. Furthermore, heightened awareness among patients and healthcare professionals regarding personalized pain management strategies further accelerates market growth.

Market Restraints:

Despite the positive outlook, the pain management therapeutics market faces challenges associated with opioid dependency, regulatory scrutiny, and the limited efficacy of certain drug classes. The ongoing opioid crisis has led to stricter prescription regulations and a decline in the use of opioids for chronic pain, posing a challenge for market growth. Additionally, concerns about adverse effects, long-term safety, and drug tolerance limit the widespread use of several conventional therapies. High treatment costs and disparities in pain management access, especially in low-income regions, further restrict market expansion and highlight the need for cost-effective, safer alternatives.

Market Opportunities:

The pain management therapeutics market presents promising opportunities driven by innovations in drug development, increased funding for pain research, and the integration of digital health tools. Emerging therapies, such as nerve growth factor inhibitors, cannabinoid-based medications, and gene therapy, are expected to reshape the treatment landscape. The expansion of telemedicine and remote patient monitoring enhances access to pain management solutions, especially in rural and underserved areas. Investment in clinical trials, combined with public-private collaborations to address unmet needs, fosters new product launches and expands treatment options for chronic and hard-to-treat pain conditions.

Key Questions Answered in the Report:

•What are the primary factors driving the growth of the pain management therapeutics market globally?
•Which drug classes and indications are most influential in shaping therapeutic preferences?
•How are safety concerns and regulatory policies influencing the evolution of the market?
•Who are the leading players in the pain management therapeutics market, and what strategies do they adopt to remain competitive?
•What are the emerging trends and innovations redefining the future of pain management?

Competitive Intelligence and Business Strategy:

Leading companies in the global pain management therapeutics market, including Pfizer Inc., Johnson & Johnson, Eli Lilly and Company, and Teva Pharmaceuticals, focus on diversifying their portfolios with innovative non-opioid analgesics and biologics. Strategic mergers, licensing agreements, and collaborative research initiatives are common approaches to accelerate product development and market penetration. These firms invest heavily in R&D to discover new pain pathways, enhance drug safety, and reduce dependency risks. Emphasis on real-world evidence, post-marketing surveillance, and patient-centric treatment protocols underscores their commitment to delivering effective and sustainable pain relief solutions.

Key Companies Profiled:

•Abbott Laboratories
•Teva Pharmaceutical
•Endo International plc
•Pfizer Inc.
•Mallinckrodt Pharmaceuticals plc
•Depomed, Inc.
•GSK plc
•Merck & Co.
•Novartis AG
•AstraZeneca plc
•Others

Pain Management Therapeutics Market Research Segmentation:

The pain management therapeutics market encompasses a diverse range of drug classes, indications, distribution channels, and end-user segments, addressing a variety of pain conditions and patient demographics.

By Drug Class

•NSAIDs
•Opioids
•Anesthetics
•Antidepressants
•Anticonvulsants
•Others

By Indication

•Arthritic Pain
•Neuropathic Pain
•Chronic Back Pain
•Cancer Pain
•Post-operative Pain
•Others

By Distribution Channel

•Online Pharmacy
•Retail Pharmacy
•Hospital Pharmacy

By Region

•North America
•Europe
•East Asia
•South Asia and Oceania
•Latin America
•Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Pain Management Therapeutics Market Snapshot, 2025-2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Key Trends
2.3. Macro-economic Factors
2.3.1. Impact of Inflation and Disposable Income on Access to Pain Management Therapies
2.3.2. Public and Private Investment Trends in Healthcare and Pain Management Therapeutics
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Drug Adoption Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. PESTLE Analysis
3.5. Porter’s Five Force Analysis
4. Pricing Analysis, 2025A
4.1. Key Highlights
4.2. Price Variation across Drug Classes and Indications
4.3. Cost Components by Drug Type and Delivery Mechanism
5. Global Pain Management Therapeutics Market Outlook
5.1. Key Highlights
5.1.1. Market Volume (Units) Projections
5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
5.3. Global Pain Management Therapeutics Market Outlook: Drug Class
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Drug Class, 2019-2024
5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025-2032
5.3.3.1. NSAIDs
5.3.3.2. Opioids
5.3.3.3. Anesthetics
5.3.3.4. Antidepressants
5.3.3.5. Anticonvulsants
5.3.3.6. Others
5.3.4. Market Attractiveness Analysis: Drug Class
5.4. Global Pain Management Therapeutics Market Outlook: Indication
5.4.1. Introduction / Key Findings
5.4.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2024
5.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
5.4.3.1. Arthritic Pain
5.4.3.2. Neuropathic Pain
5.4.3.3. Chronic Back Pain
5.4.3.4. Cancer Pain
5.4.3.5. Post-operative Pain
5.4.3.6. Others
5.4.4. Market Attractiveness Analysis: Indication
5.5. Global Pain Management Therapeutics Market Outlook: Distribution Channel
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2024
5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
5.5.3.1.
5.5.3.1.1. Online Pharmacy
5.5.3.1.2. Retail Pharmacy
5.5.3.1.3. Hospital Pharmacy
5.5.4. Market Attractiveness Analysis: Distribution Channel
6. Global Pain Management Therapeutics Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2024
6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia and Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Pain Management Therapeutics Market Outlook
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
7.2.1. By Country
7.2.2. By Drug Class
7.2.3. By Indication
7.2.4. By Distribution Channel
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
7.3.1. U.S.
7.3.2. Canada
7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025-2032
7.4.1. NSAIDs
7.4.2. Opioids
7.4.3. Anesthetics
7.4.4. Antidepressants
7.4.5. Anticonvulsants
7.4.6. Others
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
7.5.1.
7.5.1.1. Arthritic Pain
7.5.1.2. Neuropathic Pain
7.5.1.3. Chronic Back Pain
7.5.1.4. Cancer Pain
7.5.1.5. Post-operative Pain
7.5.1.6. Others
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
7.6.1. Online Pharmacy
7.6.2. Retail Pharmacy
7.6.3. Hospital Pharmacy
7.7. Market Attractiveness Analysis
8. Europe Pain Management Therapeutics Market Outlook
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
8.2.1. By Country
8.2.2. By Drug Class
8.2.3. By Indication
8.2.4. By Distribution Channel
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Turkey
8.3.8. Rest of Europe
8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025-2032
8.4.1. NSAIDs
8.4.2. Opioids
8.4.3. Anesthetics
8.4.4. Antidepressants
8.4.5. Anticonvulsants
8.4.6. Others
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
8.5.1. Arthritic Pain
8.5.2. Neuropathic Pain
8.5.3. Chronic Back Pain
8.5.4. Cancer Pain
8.5.5. Post-operative Pain
8.5.6. Others
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
8.6.1. Online Pharmacy
8.6.2. Retail Pharmacy
8.6.3. Hospital Pharmacy
8.7. Market Attractiveness Analysis
9. East Asia Pain Management Therapeutics Market Outlook
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
9.2.1. By Country
9.2.2. By Drug Class
9.2.3. By Indication
9.2.4. By Distribution Channel
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025-2032
9.4.1. NSAIDs
9.4.2. Opioids
9.4.3. Anesthetics
9.4.4. Antidepressants
9.4.5. Anticonvulsants
9.4.6. Others
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
9.5.1. Arthritic Pain
9.5.2. Neuropathic Pain
9.5.3. Chronic Back Pain
9.5.4. Cancer Pain
9.5.5. Post-operative Pain
9.5.6. Others
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
9.6.1. Online Pharmacy
9.6.2. Retail Pharmacy
9.6.3. Hospital Pharmacy
9.7. Market Attractiveness Analysis
10. South Asia & Oceania Pain Management Therapeutics Market Outlook
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
10.2.1. By Country
10.2.2. By Drug Class
10.2.3. By Indication
10.2.4. By Distribution Channel
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
10.3.1. India
10.3.2. Southeast Asia
10.3.3. ANZ
10.3.4. Rest of South Asia & Oceania
10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025-2032
10.4.1. NSAIDs
10.4.2. Opioids
10.4.3. Anesthetics
10.4.4. Antidepressants
10.4.5. Anticonvulsants
10.4.6. Others
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
10.5.1. Arthritic Pain
10.5.2. Neuropathic Pain
10.5.3. Chronic Back Pain
10.5.4. Cancer Pain
10.5.5. Post-operative Pain
10.5.6. Others
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
10.6.1. Online Pharmacy
10.6.2. Retail Pharmacy
10.6.3. Hospital Pharmacy
10.7. Market Attractiveness Analysis
11. Latin America Pain Management Therapeutics Market Outlook
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
11.2.1. By Country
11.2.2. By Drug Class
11.2.3. By Indication
11.2.4. By Distribution Channel
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025-2032
11.4.1. NSAIDs
11.4.2. Opioids
11.4.3. Anesthetics
11.4.4. Antidepressants
11.4.5. Anticonvulsants
11.4.6. Others
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
11.5.1. Arthritic Pain
11.5.2. Neuropathic Pain
11.5.3. Chronic Back Pain
11.5.4. Cancer Pain
11.5.5. Post-operative Pain
11.5.6. Others
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
11.6.1. Online Pharmacy
11.6.2. Retail Pharmacy
11.6.3. Hospital Pharmacy
11.7. Market Attractiveness Analysis
12. Middle East & Africa Pain Management Therapeutics Market Outlook
12.1. Key Highlights
12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
12.2.1. By Country
12.2.2. By Drug Class
12.2.3. By Indication
12.2.4. By Distribution Channel
12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
12.3.1. GCC Countries
12.3.2. Egypt
12.3.3. South Africa
12.3.4. Northern Africa
12.3.5. Rest of Middle East & Africa
12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025-2032
12.4.1. NSAIDs
12.4.2. Opioids
12.4.3. Anesthetics
12.4.4. Antidepressants
12.4.5. Anticonvulsants
12.4.6. Others
12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
12.5.1. Arthritic Pain
12.5.2. Neuropathic Pain
12.5.3. Chronic Back Pain
12.5.4. Cancer Pain
12.5.5. Post-operative Pain
12.5.6. Others
12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
12.6.1. Online Pharmacy
12.6.2. Retail Pharmacy
12.6.3. Hospital Pharmacy
12.7. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2025
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Abbott Laboratories
13.3.1.1. Overview
13.3.1.2. Segments and Drug Classs
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. Teva Pharmaceutical
13.3.3. Endo International plc
13.3.4. Pfizer Inc.
13.3.5. Mallinckrodt Pharmaceuticals plc
13.3.6. Depomed, Inc.
13.3.7. GSK plc
13.3.8. Merck & Co.
13.3.9. Novartis AG
13.3.10. AstraZeneca plc
13.3.11. Others
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations